Luke Furtado O’Mahony

Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score

David Chan, Aimee R. Hayes, Ioannis Karfis et al. · British Journal of Cancer · 2022 · 88 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

IMvigor011: a study of adjuvant atezolizumab in patients with high-risk MIBC who are ctDNA+ post-surgery

Francesca Jackson‐Spence, Charlotte Toms, Luke Furtado O’Mahony et al. · Future Oncology · 2023 · 68 citations

Medicine, Oncology, Surgery +17

Orbital metastases from neuroendocrine neoplasms: clinical implications and outcomes

Lukasz Kamieniarz, Eleni Armeni, Luke Furtado O’Mahony et al. · Endocrine · 2019 · 32 citations

Medicine, Oncology, Surgery +16

The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Aimee R. Hayes, Luke Furtado O’Mahony, Ann‐Marie Quigley et al. · Clinical Nuclear Medicine · 2021 · 29 citations

Medicine, Nuclear Medicine, Radiology +17

Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications

Man Liu, Eleni Armeni, Shaunak Navalkissoor et al. · Neuroendocrinology · 2020 · 21 citations

Medicine, Nuclear Medicine, Oncology +17